ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 73.70
-1.70 (-2.25%)
May 29, 2026, 1:55 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 5.31 billion as of May 29, 2026. Its market cap has increased by 127.49% in one year.
Market Cap
5.31B
Enterprise Value
4.35B
Revenue
38.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
73.70
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 5.31B, an increase of 436.32%. That is a compound annual growth rate of 41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.31B | 31.49% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.41B |
| Savior Lifetec | 5.96B |
| Sinphar Pharmaceutical | 5.84B |
| Mycenax Biotech | 5.66B |
| AnnJi Pharmaceutical | 5.47B |
| Panion & Bf Biotech | 5.12B |
| UnicoCell Biomed | 5.08B |
| Sinew Pharma | 4.77B |